Cholesteatoma of middle ear
Chapter 8:Diseases of the ear and mastoid process
ICD-10 H71 is a billable code used to indicate a diagnosis of cholesteatoma of middle ear.
Cholesteatoma of the middle ear is an abnormal skin growth that can develop in the middle ear behind the eardrum. It often arises as a complication of chronic otitis media, where repeated infections lead to the accumulation of skin cells and other debris. This growth can erode the surrounding structures, including the ossicles, and may lead to hearing loss, pain, and potential complications such as mastoiditis or intracranial infections. Patients may present with symptoms such as ear discharge, hearing loss, and a sensation of fullness in the ear. Diagnosis typically involves otoscopic examination, audiometric testing, and imaging studies like CT scans to assess the extent of the cholesteatoma and any associated complications. Management often requires surgical intervention to remove the cholesteatoma and reconstruct the tympanic membrane and ossicular chain, with follow-up care to monitor for recurrence.
Detailed operative reports, audiometric evaluations, and imaging studies.
Patients presenting with chronic ear infections, hearing loss, or post-operative follow-ups.
Ensure accurate coding of surgical interventions and any complications that arise.
Comprehensive audiometric testing results and patient history.
Assessment of hearing loss in patients with known cholesteatoma.
Document the impact of cholesteatoma on hearing and any rehabilitative measures taken.
Performed to remove cholesteatoma and reconstruct the tympanic membrane.
Operative report detailing the procedure and findings.
Otolaryngologists must document the extent of the cholesteatoma and any complications.
Cholesteatoma is primarily caused by chronic eustachian tube dysfunction, leading to negative pressure in the middle ear and subsequent accumulation of skin cells.
Diagnosis is made through clinical examination, audiometric testing, and imaging studies such as CT scans to assess the extent of the disease.
Treatment typically involves surgical removal of the cholesteatoma and reconstruction of the tympanic membrane and ossicular chain, with follow-up care to monitor for recurrence.
